Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
NCT01507389
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
liraglutide
Sponsor
Novo Nordisk A/S